Cargando…

Macrophage DCLK1 promotes obesity-induced cardiomyopathy via activating RIP2/TAK1 signaling pathway

Obesity increases the risk for cardiovascular diseases and induces cardiomyopathy. Chronic inflammation plays a significant role in obesity-induced cardiomyopathy and may provide new therapeutic targets for this disease. Doublecortin-like kinase 1 (DCLK1) is an important target for cancer therapy an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Bin, Zhao, Yunjie, Luo, Wu, Zhu, Weiwei, Jin, Leiming, Wang, Minxiu, Ye, Lin, Wang, Yi, Liang, Guang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345119/ https://www.ncbi.nlm.nih.gov/pubmed/37443105 http://dx.doi.org/10.1038/s41419-023-05960-4

Ejemplares similares

Macrophage DCLK1 promotes atherosclerosis via binding to IKKβ and inducing inflammatory responses
por: Huang, Zhuqi, et al.
Publicado: (2023)

TAK1 inhibition-induced RIP1-dependent apoptosis in murine macrophages relies on constitutive TNF-α signaling and ROS production
por: Wang, Jang-Shiun, et al.
Publicado: (2015)

The Prevalence of TNFα-Induced Necrosis over Apoptosis Is Determined by TAK1-RIP1 Interplay
por: Çöl Arslan, Seda, et al.
Publicado: (2011)

Inhibition of DCLK1 with DCLK1-IN-1 Suppresses Renal Cell Carcinoma Invasion and Stemness and Promotes Cytotoxic T-Cell-Mediated Anti-Tumor Immunity
por: Ding, Ling, et al.
Publicado: (2021)

DCLK1 immunoreactivity in colorectal neoplasia
por: Gagliardi, Giuseppe, et al.
Publicado: (2012)

DCLK1 autoinhibition and activation in tumorigenesis
por: Cheng, Linna, et al.
Publicado: (2021)

Analysis of the clinical significance of DCLK1(+) colorectal cancer using novel monoclonal antibodies against DCLK1
por: Dai, Tianqi, et al.
Publicado: (2018)

Structural Basis of Inhibition of DCLK1 by Ruxolitinib
por: Jang, Dong Man, et al.
Publicado: (2021)

DCLK1 Plays a Metastatic-Promoting Role in Human Breast Cancer Cells
por: Liu, Heshu, et al.
Publicado: (2019)

Pleiotropic effects of DCLK1 in cancer and cancer stem cells
por: Chhetri, Dibyashree, et al.
Publicado: (2022)

RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome
por: Zhang, Yingying, et al.
Publicado: (2017)

Activated Macrophage Survival Is Coordinated by TAK1 Binding Proteins
por: Mihaly, September R., et al.
Publicado: (2014)

TAK1 regulates resident macrophages by protecting lysosomal integrity
por: Sakamachi, Yosuke, et al.
Publicado: (2017)

FAK mediates LPS-induced inflammatory lung injury through interacting TAK1 and activating TAK1-NFκB pathway
por: Chen, Xi, et al.
Publicado: (2022)

XMD-17-51 Inhibits DCLK1 Kinase and Prevents Lung Cancer Progression
por: Yang, Wei-Qiang, et al.
Publicado: (2021)

TAK1 deficiency promotes liver injury and tumorigenesis via ferroptosis and macrophage cGAS-STING signalling
por: Su, Wantong, et al.
Publicado: (2023)

DCLK1, a Putative Stem Cell Marker in Human Cholangiocarcinoma
por: Lorenzo, Nevi, et al.
Publicado: (2021)

DCLK1 Inhibition Sensitizes Colorectal Cancer Cells to Radiation Treatment
por: Mohammadi, Chiman, et al.
Publicado: (2021)

Structure-Guided Prediction of the Functional Impact of DCLK1 Mutations on Tumorigenesis
por: Carli, Annalisa L. E., et al.
Publicado: (2023)

Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism
por: Sureban, Sripathi M., et al.
Publicado: (2015)

DCLK1 promotes colorectal cancer stemness and aggressiveness via the XRCC5/COX2 axis
por: Kim, Jee-Heun, et al.
Publicado: (2022)

RIP1 kinase mediates angiogenesis by modulating macrophages in experimental neovascularization
por: Ueta, Takashi, et al.
Publicado: (2019)

Co-localization of autophagy-related protein p62 with cancer stem cell marker dclk1 may hamper dclk1's elimination during colon cancer development and progression
por: Roy, Badal Chandra, et al.
Publicado: (2019)

TAK1ng control: TAK1 restrains NLRP3 activation
por: Mangan, Matthew Stephen, et al.
Publicado: (2018)

Structural basis for small molecule targeting of Doublecortin Like Kinase 1 with DCLK1-IN-1
por: Patel, Onisha, et al.
Publicado: (2021)

HDAC6-dependent deacetylation of TAK1 enhances sIL-6R release to promote macrophage M2 polarization in colon cancer
por: Xu, Guangying, et al.
Publicado: (2022)

DCLK1 Variants Are Associated across Schizophrenia and Attention Deficit/Hyperactivity Disorder
por: Håvik, Bjarte, et al.
Publicado: (2012)

Expression of alternatively spliced variants of the Dclk1 gene is regulated by psychotropic drugs
por: Zygmunt, Magdalena, et al.
Publicado: (2018)

Regulatory Roles of Dclk1 in Epithelial Mesenchymal Transition and Cancer Stem Cells
por: Chandrakesan, P, et al.
Publicado: (2016)

DCLK1 and its interaction partners: An effective therapeutic target for colorectal cancer
por: Vijai, Muthu, et al.
Publicado: (2021)

DCLK1 isoforms and aberrant Notch signaling in the regulation of human and murine colitis
por: Roy, Badal C., et al.
Publicado: (2021)

Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: Clinical Implications
por: O’Connell, Malaney R., et al.
Publicado: (2015)

DCLK1 is correlated with MET and ERK5 expression, and associated with prognosis in malignant pleural mesothelioma
por: Wang, Hui, et al.
Publicado: (2017)

A Novel Class of RIP1/RIP3 Dual Inhibitors
por: Zhou, Ting, et al.
Publicado: (2020)

CARD3 Promotes Cerebral Ischemia‐Reperfusion Injury Via Activation of TAK1
por: Wu, Xiaolin, et al.
Publicado: (2020)

Dclk1(+) small intestinal epithelial tuft cells display the hallmarks of quiescence and self-renewal
por: Chandrakesan, Parthasarathy, et al.
Publicado: (2015)

Application of RNA Sequencing to identify transcriptome modification by DCLK1 in Colorectal Cancer Cells
por: Li, Lianna, et al.
Publicado: (2019)

Correction: DCLK1 isoforms and aberrant Notch signaling in the regulation of human and murine colitis
por: Roy, Badal C., et al.
Publicado: (2021)

RIP1-driven autoinflammation targets IL-1α independently of inflammasomes and RIP3
por: Lukens, John R., et al.
Publicado: (2013)

Life after death: RIP1 and RIP3 move beyond necroptosis
por: Berger, SB, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tmnvjpbomg0o0a4b5do1tk630d